Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Lab on a Chip|September 22, 2015
Digital quantification of miRNA directly in plasma using integrated comprehensive droplet digital detectionKaixiang Zhang, Dong-Ku Kang, M Monsur Ali, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|December 8, 2022
A human vascularized microtumor model of patient-derived colorectal cancer recapitulates clinical diseaseStephanie J Hachey, Agua Sobrino, John G Lee, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 18, 2024
Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic CancerClaudia Rosso, Naomie Devico Marciano, Deepika Nathan, et al.Cancer Prevention Research (Philadelphia, Pa.)|April 6, 2011
Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasmsSteven Lipkin, John Lee, David Imagawa, et al.Cancer Prevention Research (Philadelphia, Pa.)|December 11, 2019
A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass IndexJason A Zell, Christine E McLaren, Timothy R Morgan, et al.Journal of Surgical Oncology|June 19, 2024
The impact of the California state lockdown during the COVID-19 pandemic on management of patients with pancreatic ductal adenocarcinomaParisa Oviedo, Shohei Burns, Wen-Pin Chen, et al.Journal of the National Cancer Institute|August 3, 2023
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancerHagen F Kennecke, Rebecca Auer, May Cho, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 22, 2015
A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectumDaniel L Gillen, Frank L Meyskens, Timothy R Morgan, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 14, 2023
Clinical implications of conflicting variant interpretations in the cancer genetics clinicElyssa Zukin, Julie O Culver, Yuxi Liu, et al.Journal of the National Cancer Institute|July 2, 2026
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICEKatherine D Crew, Garnet L Anderson, Kathryn B Arnold, et al.Pageof 10